Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-13 is a driver of COVID-19 severity
Alexandra N. Donlan, Tara E. Sutherland, Chelsea Marie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Leandro Moretti, Jack Stalfort, Thomas H. Barker, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 2, pp. 101530-101530
Open Access | Times Cited: 219
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 70
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Peter Radvák, Hyung‐Joon Kwon, Martina Košíková, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 94
COVID-19—Lessons Learned and Questions Remaining
Ferric C. Fang, Constance A. Benson, Carlos del Rı́o, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2225-2240
Open Access | Times Cited: 77
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62
COVID‐19 immunopathology: From acute diseases to chronic sequelae
Mohd Arish, Wei Qian, Harish Narasimhan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 45
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 9
Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
T. Matsuyama, Steven K. Yoshinaga, Kimitaka Shibue, et al.
Cell Death and Differentiation (2021) Vol. 28, Iss. 12, pp. 3199-3213
Open Access | Times Cited: 48
Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections
Michael J. Kratochvil, Gernot Kaber, Sally Demirdjian, et al.
JCI Insight (2022) Vol. 7, Iss. 12
Open Access | Times Cited: 30
Expression and co-expression analyses of TMPRSS2, a key element in COVID-19
Francesco Piva, Berina Šabanović, Monia Cecati, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2020) Vol. 40, Iss. 2, pp. 451-455
Open Access | Times Cited: 44
Oral hymecromone decreases hyaluronan in human study participants
Joelle I. Rosser, Nadine Nagy, Riya Goel, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 25
Early alveolar epithelial cell necrosis is a potential driver of COVID-19-induced acute respiratory distress syndrome
Kentaro Tojo, Natsuhiro Yamamoto, Nao Tamada, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105748-105748
Open Access | Times Cited: 23
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review
Jennifer Sasson, G. Brett Moreau, William A. Petri
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 6, pp. 727-732
Open Access | Times Cited: 16
Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation
Oyebola O. Oyesola, Kerry L. Hilligan, Sivaranjani Namasivayam, et al.
Science Immunology (2023) Vol. 8, Iss. 86
Closed Access | Times Cited: 16
Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hani Faidah, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 29
Highly pathogenic PRRSV upregulates IL-13 production through nonstructural protein 9–mediated inhibition of N6-methyladenosine demethylase FTO
Xingyu Gong, Liang Yuan, Jingjing Wang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 4, pp. 107199-107199
Open Access | Times Cited: 4
There’s no place like home: How local tissue microenvironments shape the function of innate lymphoid cells
Luke B. Roberts, Alanna M. Kelly, Matthew R. Hepworth
Mucosal Immunology (2025)
Open Access
Comparative Analysis Between Olink‐PEA and Alamar‐NULISA Proteomic Technologies Applied to a Critically Ill COVID‐19 Cohort
Sara Taleb, Nisha Stephan, Sareena Chennakkandathil, et al.
PROTEOMICS (2025)
Closed Access
DeepEpiIL13: Deep Learning for Rapid and Accurate Prediction of IL-13-Inducing Epitopes Using Pretrained Language Models and Multiwindow Convolutional Neural Networks
Cheng-Che Chuang, Yu-Chen Liu, Yu‐Yen Ou
ACS Omega (2025) Vol. 10, Iss. 9, pp. 9675-9683
Open Access
Deep learning model to predict the need for mechanical ventilation using chest X-ray images in hospitalised patients with COVID-19
Anoop R Kulkarni, Ambarish M. Athavale, Ashima Sahni, et al.
BMJ Innovations (2021) Vol. 7, Iss. 2, pp. 261-270
Open Access | Times Cited: 24
Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
Abdulraheem Y. Majeed, Nor Effa S. Zulkafli, Ali H. Ad’hiah
Immunology Letters (2023) Vol. 260, pp. 24-34
Open Access | Times Cited: 10
Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial
Jennifer Hendrick, Z. Jennie, Heather M. Haughey, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 2
Open Access | Times Cited: 3
SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study
Urban Hellman, Ebba Rosendal, Joakim Lehrstrand, et al.
mBio (2024)
Open Access | Times Cited: 3
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome
Marwan M. Azar, Junghee J. Shin, Insoo Kang, et al.
Expert Review of Molecular Diagnostics (2020) Vol. 20, Iss. 11, pp. 1087-1097
Closed Access | Times Cited: 27
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals
Jean‐Eudes Fahrner, Imran Lahmar, Anne‐Gaëlle Goubet, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 958-983
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top